← FDA Drug Approvals (Drugs@FDA)

QBREXZA

NDA · New Drug Application · Sponsor: JOURNEY · Approved 2018-06-28

Drug application

FDA Application #

NDA210361

Application type

New Drug Application

Brand name

QBREXZA

Generic name

GLYCOPYRRONIUM

Active ingredients

GLYCOPYRRONIUM TOSYLATE

Dosage form

CLOTH

Route

TOPICAL

Marketing status

Prescription

Sponsor

JOURNEY

Manufacturer

Journey Medical Corporation

First approval

2018-06-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown